1,2,3,4-Tetrahydroquinazoline-4-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 1,2,3,4-Tetrahydroquinazoline-4-carboxylic acid
• 英文别名: 1,2,3,4-tetrahydroquinazoline-4-carboxylic acid
• 化学式: C₉H₁₀N₂O₂
• 分子量: 178.19
• InChiKey: UTHDIHIMGWSONJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  61.4
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• [EN] SMALL MOLECULE MODULATORS OF HUMAN STING<br/>[FR] MODULATEURS À PETITES MOLÉCULES DE STING HUMAIN
  申请人：CURADEV PHARMA LTD

  公开号：WO2018234808A1

  公开（公告）日：2018-12-27

  The present invention relates to compounds of formula (I). The compounds maybe used to modulate the Stimulator of Interferon Genes (STING) protein and thereby treat diseases such as cancer and microbial infections.

  本发明涉及式(I)的化合物。这些化合物可以用于调节干扰素基因激活蛋白（STING）并因此治疗癌症和微生物感染等疾病。
• SMALL MOLECULE MODULATORS OF HUMAN STING
  申请人：Curadev Pharma Limited

  公开号：EP3642198A1

  公开（公告）日：2020-04-29
• SMALL MOLECULE STING ANTAGONISTS
  申请人：Curadev Pharma Pvt. Ltd.

  公开号：EP4103278A1

  公开（公告）日：2022-12-21
• [EN] SMALL MOLECULE STING ANTAGONISTS<br/>[FR] ANTAGONISTES DE STING À PETITES MOLÉCULES
  申请人：CURADEV PHARMA PVT LTD

  公开号：WO2021161230A1

  公开（公告）日：2021-08-19

  The present invention relates to compounds of formula (I). The compounds maybe used to antagonise the Stimulator of Interferon Genes (STING) protein and may thereby treat liver fibrosis, fatty liver disease, non-alcoholic steatohepatitis (NASH), pulmonary fibrosis, lupus, sepsis, rheumatoid arthritis (RA), type I diabetes, STING- associated vasculopathy with onset in infancy (SAVI), Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus (SLE), retinal vasculopathy, neuroinflammation, systemic inflammatory response syndrome, pancreatitis, cardiovascular disease, renal fibrosis, stroke and age-related macular degeneration (AMD).